Bristol-Myers Squibb
BMY
BMY
1,812 hedge funds and large institutions have $69.6B invested in Bristol-Myers Squibb in 2019 Q3 according to their latest regulatory filings, with 147 funds opening new positions, 725 increasing their positions, 704 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 1,776 → 1,812 (+36)
3% more repeat investments, than reductions
Existing positions increased: 725 | Existing positions reduced: 704
2% less call options, than puts
Call options by funds: $1.66B | Put options by funds: $1.7B
Holders
1,812
Holding in Top 10
48
Calls
$1.66B
Puts
$1.7B
Top Buyers
| 1 | +$567M | |
| 2 | +$504M | |
| 3 | +$433M | |
| 4 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
+$370M |
| 5 |
AIG
American International Group
New York
|
+$357M |
Top Sellers
| 1 | -$311M | |
| 2 | -$218M | |
| 3 | -$185M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$159M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
-$141M |